Bianchi Giuseppe Professore EmeritoMedicine

Giuseppe Bianchi, MD, Milan University. Training in Pharmacology cardiovascular-renal pathophysiology, biochemistry and clinic in Pharma Companies, Universities of Milan, Parma, Padua, London and Glasgow, PhD in Pharmacology, Specialities in Cardiology and Nephrology. Honorary MD at the Universities of Berlin and Uppsala, awards from British, American, and Italian societies of Hypertension, National Kidney Foundation USA, International Union of Physiological Science USA, Accademia dei Lincei Rome, University of Naples and other scientific organizations.

Former Director of the Division of Nephrology, Dialysis and Hypertension, Chair and School of Nephrology, “Vita Salute” San Raffaele University, Milan University and past Scientific Director of the Prassis Sigma-Tau Cardiovascular Research Institute and of CVie Therapeutic Taiwan and China and past CSO at Windtree Therapeutics USA.

Present: Professor Emeritus at the “Vita Salute” San Raffaele University.

Past and present member of the Editorial Boards of 12 international journals and invited speaker or chairman at more than 600 national and international meetings. He has published more than 300 articles in peer-review journals (including Lancet, J Clin Invest, New Engl J med, PNAS, Science Trans Med etc.)  and more than 200 chapters in books or in meeting proceedings. Over the years, Prof. Bianchi has combined his academic and clinical experience with parallel work in collaboration with pharmaceutical companies (Lepetit S.p.A., Farmitalia Carlo Erba, Prassis Sigma-Tau S.p.A., CVie Therapeutics Taiwan and Windtree Therapeutics USA) in order to develop a targeted therapeutic approach to cardiovascular diseases through laboratory and clinical practice.